Aberrant MYC expression in cancer is mainly regulated at transcriptional level [57] by a complex mechanism involving four promoters (P1–P4), different transcription start sites and nuclease hypersensitive elements (NHE) [59]. The gene discussed is MYC; the disease is cancer.